RecruitingPhase 1NCT06879041
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: AstraZeneca
Omaha, NE · +11 more sites
Prostate Cancer clinical trials in Omaha, NE
21 recruiting prostate cancer studies with a site in Omaha, NE.
RecruitingPhase 1NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Sponsor: Pfizer
Omaha, NE · +44 more sites
RecruitingPhase 1 / Phase 2NCT07590934
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Omaha, NE · +11 more sites
RecruitingPhase 2NCT07745361
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Sponsor: Monte Rosa Therapeutics, Inc
Omaha, NE · +13 more sites
RecruitingPhase 1 / Phase 2NCT07189871
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Sponsor: Radiopharm Theranostics, Ltd
Omaha, NE · +3 more sites
RecruitingPhase 1 / Phase 2NCT06800313
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Sponsor: Janssen Research & Development, LLC
Omaha, NE · +16 more sites
RecruitingPhase 1NCT06801236
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Acerand Therapeutics (Hong Kong) Limited
Omaha, NE · +7 more sites
RecruitingPhase 2 / Phase 3NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Sponsor: Novartis Pharmaceuticals
Omaha, NE · +34 more sites
RecruitingPhase 2NCT07234981
PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
Sponsor: University of Nebraska
Omaha, NE
RecruitingPhase 1NCT07581184
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Aktis Oncology, Inc.
Omaha, NE · +5 more sites
RecruitingPhase 3NCT06056830
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Sponsor: Clarity Pharmaceuticals Ltd
Omaha, NE · +28 more sites
RecruitingPhase 3NCT04423211
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Sponsor: ECOG-ACRIN Cancer Research Group
Kearney, NE · Omaha, NE · +338 more sites
RecruitingPhase 2NCT07237269
Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
Sponsor: University of Nebraska
Omaha, NE
RecruitingPhase 3NCT06592924
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Sponsor: Canadian Cancer Trials Group
Grand Island, NE · Kearney, NE · Omaha, NE · +371 more sites
RecruitingPhase 1NCT06217822
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
Sponsor: Bayer
Omaha, NE · +3 more sites
RecruitingPhase not listedNCT02012699
Integrated Cancer Repository for Cancer Research
Sponsor: University of Nebraska
Hastings, NE · Norfolk, NE · North Platte, NE · +39 more sites
RecruitingPhase 1NCT05283330
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Sponsor: Orano Med Theranostics, SAS
Omaha, NE · +6 more sites
RecruitingPhase 1 / Phase 2NCT05413850
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Sponsor: Blue Earth Therapeutics Ltd
Omaha, NE · +4 more sites
RecruitingPhase 3NCT06470243
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Sponsor: SWOG Cancer Research Network
Bellevue, NE · Omaha, NE · +171 more sites
Not yet recruitingPhase 1 / Phase 2NCT07668284
COQ10 and Vitamin E for Off-Target Radiation Toxicity
Sponsor: University of Nebraska
Omaha, NE
Not yet recruitingPhase 2 / Phase 3NCT07574489
Whole Versus Partial Gland Boost During Prostate SBRT
Sponsor: University of Nebraska
Omaha, NE
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.